Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Redemption value adjustments

Similar metrics at other companies

Flutter Entertainment logo
FLUTAdjustment to the redemption value
$2M+102%
Lifecore Biomedical, Inc. logo
LFCRAdjustment to the redemption value
$47K—
Organogenesis Holdings Inc. logo
ORGOAdjustment to the redemption value
$170K+31.8%
Blend Labs logo
BLNDAdjustment to the redemption value
$4.93M+12.6%
Blend Labs logo
BLNDTemporary Equity Accretion To Redemption Value Adjustment
$4.93M+12.6%
Medtronic logo
MDTMedical Surgical — Depreciation
$56M+5.7%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234

(3) Includes redemption value adjustments of $293 million and $81 million related to the Medical-Surgical Solutions business and Core Ventures, respectively, for the three months ended June 30, 2026.

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — redemption value adjustments?
McKesson (MCK) reported medical-surgical solutions — redemption value adjustments of $293M in Q2 2026.
What does medical-surgical solutions — redemption value adjustments mean?
This metric represents the periodic adjustments made to the redemption value of non-controlling interests or specific equity-linked obligations within the Medical-Surgical Solutions segment. These adjustments reflect changes in the estimated fair value of obligations that the company may be required to settle in cash or other assets. Monitoring these adjustments is essential for understanding the impact of minority interest buyouts or contractual put options on the segment's reported financial performance.

Ask your AI about McKesson's medical-surgical solutions — redemption value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude